(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 10.73%4.61B | 8.45%2.14B | 11.74%8.53B | 12.66%6.22B | 12.93%4.16B | 6.33%1.97B | 19.86%7.64B | 21.43%5.52B | 21.32%3.69B | 18.81%1.85B |
Operating income | 10.73%4.61B | 8.45%2.14B | 11.74%8.53B | 12.66%6.22B | 12.93%4.16B | 6.33%1.97B | 19.86%7.64B | 21.43%5.52B | 21.32%3.69B | 18.81%1.85B |
Cost of sales | -17.18%-827.95M | -14.88%-396.22M | -2.98%-1.5B | -0.11%-1.09B | 1.48%-706.56M | 1.65%-344.91M | -26.15%-1.46B | -38.69%-1.09B | -39.15%-717.18M | -43.88%-350.68M |
Operating expenses | -17.18%-827.95M | -14.88%-396.22M | -2.98%-1.5B | -0.11%-1.09B | 1.48%-706.56M | 1.65%-344.91M | -26.15%-1.46B | -38.69%-1.09B | -39.15%-717.18M | -43.88%-350.68M |
Gross profit | 9.41%3.78B | 7.09%1.74B | 13.81%7.03B | 15.73%5.13B | 16.41%3.46B | 8.19%1.63B | 18.46%6.18B | 17.84%4.44B | 17.68%2.97B | 14.17%1.5B |
Selling expenses | 1.76%-640.7M | 25.59%-261.29M | -18.35%-1.47B | -20.45%-1.09B | -18.15%-652.2M | -30.51%-351.15M | -16.67%-1.24B | -19.88%-907.68M | -7.27%-552.03M | -31.56%-269.07M |
Administrative expenses | -4.11%-315.63M | -7.00%-160.27M | -6.86%-661.43M | -7.41%-490.3M | -0.93%-303.16M | -1.73%-149.79M | -8.59%-618.96M | -10.11%-456.48M | -6.92%-300.38M | 0.25%-147.25M |
Research and development expenses | -9.60%-1.45B | -7.83%-712.79M | -5.13%-2.68B | -5.63%-2B | -6.09%-1.33B | -8.68%-661.06M | -9.65%-2.55B | -15.11%-1.89B | -22.25%-1.25B | -23.88%-608.26M |
Special items of operating profit | 159.52%23.3M | -52.82%-4.72M | -88.61%12.06M | -156.71%-39.77M | -176.56%-39.15M | -114.25%-3.09M | -3.08%105.91M | -12.29%70.13M | 39.67%51.14M | -44.87%21.69M |
Operating profit | 22.85%1.4B | 30.69%601.58M | 19.17%2.23B | 20.97%1.51B | 23.72%1.14B | -7.84%460.3M | 37.34%1.87B | 21.45%1.25B | 23.76%918.18M | -2.46%499.45M |
Financing income | 28.14%351.15M | 39.87%188.58M | 40.13%629.2M | 35.84%450.07M | 22.11%274.03M | 17.22%134.83M | 7.87%449.01M | 9.94%331.33M | 16.42%224.4M | 27.76%115.02M |
Financing cost | -7.11%-88.33M | -6.96%-43.6M | -7.27%-168.89M | -8.75%-125.54M | -9.11%-82.47M | -10.17%-40.76M | -10.26%-157.44M | -7.64%-115.44M | -6.21%-75.59M | -5.23%-37M |
Share of profits of associates | 38.96%-337.91M | 26.88%-168.72M | 15.85%-1.15B | 22.24%-860.47M | 20.05%-553.56M | 15.98%-230.76M | -4.64%-1.36B | -53.31%-1.11B | -58.91%-692.36M | -22.11%-274.65M |
Share of profit from joint venture company | -162.47%-15.1M | -152.43%-9.62M | -1.58%-19.95M | -55.79%-10.27M | -123.59%-5.75M | -25.21%-3.81M | 38.01%-19.63M | 70.26%-6.59M | 83.75%-2.57M | 66.57%-3.04M |
Special items of earning before tax | 71.73%-16.58M | -109.78%-4.31M | 99.51%-32.16M | 99.37%-40.55M | -303.66%-58.65M | 91.27%44.04M | -871.59%-6.5B | -892.64%-6.46B | -64.35%28.8M | -30.20%23.03M |
Earning before tax | 81.63%1.29B | 54.99%563.92M | 126.02%1.49B | 115.16%925.34M | 77.02%709.61M | 12.71%363.85M | -600.50%-5.72B | -571.77%-6.11B | -18.64%400.86M | -11.78%322.81M |
Tax | 12.68%-90.71M | -63.44%-42.34M | -172.12%-273.66M | -128.09%-147.71M | -60.01%-103.88M | 25.81%-25.9M | 299.41%379.46M | 482.17%525.87M | -61.66%-64.92M | 47.20%-34.92M |
After-tax profit from continuing operations | 97.80%1.2B | 54.34%521.59M | 122.75%1.22B | 113.94%777.63M | 80.31%605.73M | 17.39%337.95M | -660.63%-5.34B | -582.43%-5.58B | -25.77%335.94M | -3.96%287.9M |
Earning after tax | 97.80%1.2B | 54.34%521.59M | 122.75%1.22B | 113.94%777.63M | 80.31%605.73M | 17.39%337.95M | -660.63%-5.34B | -582.43%-5.58B | -25.77%335.94M | -3.96%287.9M |
Minority profit | 46.05%520.21M | 62.78%237.02M | 3.42%731.73M | -3.10%499.61M | -5.77%356.2M | -23.27%145.61M | 26.91%707.52M | 21.01%515.59M | 31.56%378M | 3.58%189.75M |
Profit attributable to shareholders | 171.68%677.92M | 47.95%284.57M | 107.99%483.46M | 104.56%278.02M | 693.22%249.53M | 95.98%192.34M | -1,630.21%-6.05B | -934.43%-6.09B | -125.46%-42.06M | -15.81%98.14M |
Basic earnings per share | 183.33%0.51 | 50.00%0.21 | 108.13%0.36 | 104.47%0.2 | 700.00%0.18 | 100.00%0.14 | -1,627.59%-4.43 | -943.40%-4.47 | -125.00%-0.03 | -22.22%0.07 |
Diluted earnings per share | 188.24%0.49 | 50.00%0.21 | 107.64%0.34 | 104.23%0.19 | 440.00%0.17 | 133.33%0.14 | -1,689.29%-4.45 | -947.17%-4.49 | -141.67%-0.05 | -25.00%0.06 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data